Development of a chimeric recombinant disintegrin as a cost-effective anticancer agent with promising translational potential

Por Minea, Radu, Helchowski, Corey, Rubino, Barbara, Brodmann, Kyle, Swenson, Stephen, Markland, Francis
Publicado em 2011